Clover Health Investments, Corp.
CLOV
$2.67
-$0.005-0.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.83% | 38.17% | |||
| Total Other Revenue | 43.67% | -13.66% | |||
| Total Revenue | 3.31% | 37.21% | |||
| Cost of Revenue | 6.95% | 45.42% | |||
| Gross Profit | -8.50% | 15.94% | |||
| SG&A Expenses | 0.09% | -4.63% | |||
| Depreciation & Amortization | -15.45% | 35.47% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.30% | 29.35% | |||
| Operating Income | -728.81% | 94.06% | |||
| Income Before Tax | -730.30% | 94.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -730.30% | 94.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -730.30% | 94.23% | |||
| EBIT | -728.81% | 94.06% | |||
| EBITDA | -1,158.04% | 96.17% | |||
| EPS Basic | -700.00% | 94.21% | |||
| Normalized Basic EPS | -712.50% | 94.14% | |||
| EPS Diluted | -700.00% | 94.30% | |||
| Normalized Diluted EPS | -712.50% | 94.14% | |||
| Average Basic Shares Outstanding | 2.41% | 1.05% | |||
| Average Diluted Shares Outstanding | 2.41% | 1.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||